Back to Results
Practice patterns and outcomes of ACTHar use in children with nephrotic syndrome
| Title |
Practice patterns and outcomes of ACTHar use in children with nephrotic syndrome |
| Therapeutic Area |
Nephrotic Syndrome (Floating)
|
| Principal Investigator |
Lawrence Milner, MD |
| Min Age |
0 Years |
| Max Age |
21 Years |
| Gender |
All |
| Contact |
Lawrence Milner, mD
617 636-7016
lmilner@tuftsmedicalcenter.org
|
This is a registry study which will collect safety health information from children 6 months to 21 years of age with nephrotic syndrome of any cause, and treated with ACTHar therapy. All the data collection will take place during the routine hospital visits. There is no additional visits and invasive procedures for this study.
Inclusion Criteria
- Children 6 months to 21 years of age with nephrotic syndrome of any cause
- Treated with ACTHar therapy.
Exclusion Criteria
Study Requirements
This is a registry study which will collect safety information only. No additional research visits. no invasive procedures.
